The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States
Authors:
- Trisha L AmboreeTATrisha L Amboree
- Poria DoraliPDPoria Dorali
- Haluk DamgaciogluHDHaluk Damgacioglu
- Marvella E FordMFMarvella E Ford
- Brian OrrBOBrian Orr
- Gweneth LazenbyGLGweneth Lazenby
- Britton GibsonBGBritton Gibson
- Ana P OrtizAOAna P Ortiz
- Tonatiuh Suárez RamosTRTonatiuh Suárez Ramos
- Kalyani SonawaneKSKalyani Sonawane
- Ashish A DeshmukhADAshish A Deshmukh
Open Access
- 9 January 2026
- journal article
- Published by Oxford University Press (OUP) in JNCI Cancer Spectrum
- Vol. 10 (1)
Abstract
Cervical cancer elimination (<4 cases per 100 000) is a critical cancer prevention goal in the United States. Implementation of health policies and allocation of health resources occur at regional and state levels; therefore, understanding region- and state-specific cervical cancer incidence, mortality, and progress toward elimination—and remaining gaps—is essential. We estimated hysterectomy-corrected cervical cancer incidence, mortality, and progress toward elimination across all 50 states, the District of Columbia, and Puerto Rico. In 2021, Massachusetts was the only state nearing (4.3 per 100 000) the elimination threshold. Southeastern and Southwestern states were furthest, with the highest incidence rates in Mississippi (14.8), Louisiana (14.2), and Oklahoma (13.8). The mortality rate ranged from 6.8 (Alabama) to 1.4 (Wisconsin). In most states, cervical cancer incidence and mortality did not change from 2007-2011 to 2017-2021. Identifying and addressing regional- and state-level barriers impeding progress will be key to achieving cervical cancer elimination.Keywords
Funding Information
- American Cancer Society Institutional Research Grant (#IRG-24-1290553-23-IRG)
- National Cancer Institute (R01CA282424)
- National Library of Medicine (G08LM014413)
- Hollings Cancer Center (P30CA138313)
- MD Anderson Cancer Center (P30CA016672)
This publication has 13 references indexed in Scilit:
- National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health CentersJAMA Network Open, 2025
- State-Level Public Awareness of HPV, HPV Vaccine, and Association With CancerJAMA Oncology, 2025
- Rural-Urban Disparities in Cervical Cancer Incidence and Mortality Among US WomenJAMA Network Open, 2025
- Cervical Cancer Mortality Among US Women Younger Than 25 Years, 1992-2021JAMA, 2025
- National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health CentersJAMA Internal Medicine, 2024
- Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county‐level income in the United States, 2000–2019International Journal of Cancer, 2024
- County-Level Trends in Cervical Cancer Incidence, Stage at Diagnosis, and Mortality in KentuckyJAMA Network Open, 2023
- Cervical Cancer Incidence Among US Women, 2001-2019JAMA, 2022
- Prevalence of Human Papillomavirus Infection Among Women Born in the 1990s vs the 1980s and Association With HPV Vaccination in the USJAMA Health Forum, 2022
- US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer ratesCancer Causes & Control, 2021